2019 Speakers

Nusayba Anjarwalla is an Engagement Manager in the Global Pricing, Market Access and Analytics line of Precision Xtract. Nusayba has 3.5 years consulting experience in a variety of therapeutic areas, including oncology, cardio-vascular disease, ophtmamology and obesity. Her current projects include ...

Francis Arickx is the secretary for the Commission for Reimbursement of Medicines at the National Institute for Health and Disability Insurance (NIHDI RIZIV/INAMI) in Belgium.  In the directorate Pharmaceutical Policy within the Health Department, he manages the teams responsible for administrative ...

Nadeem Ashraf is a medical advisor- diabetes for a pharmaceutical company in the UK.  Nadeem is registered with General Medical Council- UK  as a medical doctor and holds 15 years of cross functional experience across the Pharmaceutical industry ranging from brand management & sales leadership...

Matthew Bending, PhD, is the Senior Principal and Executive Director of HTA Strategy, Market Access Consulting at Evidera. Dr. Bending is a Health Economist with a PhD in Health Sciences studying the use of Health Technology Assessment (HTA) in reimbursement decision-making with over 14 years...

Director – Mike Blackney, PhD. Mike heads up the Payer Insights and Access group at Covance Market Access which focuses on delivering strategic global payer research-based projects for pharmaceutical and medical device manufacturers. Prior to joining Covance in 2010, he worked as a Research...

Pedro works as a Consultant at the London headquarters of Lifescience Dynamics. Prior to joining Lifescience Dynamics, he worked as a consulting Business Analyst at IMS Health (now IQVIA).Pedro has obtained a bench-to-bedside view of pharmaceuticals through diverse roles including translational...

Abbes is a Consultant based in our UK office and joined the firm in 2015. He is involved in market research, competitive intelligence and market access consulting projects across various therapeutic areas. Prior to joining Lifescience Dynamics, Abbes worked in several advisory firms dedicated to...

Don Creighton has more than 20 of years of experience in industry, consulting and scientific research with expert knowledge of payer systems and pricing & market access strategy.Don has worked across a broad array of therapy areas and geographies with projects spanning the development continuum ...

Alan has spent close to 20 years doing commercial work for the life sciences industry. His experience includes creating innovative solutions for global pricing and access, including work on price optimization, global data collection and analysis, and the use of advanced algorithms to support...

Stephen Deitch is a vice president in the Life Sciences Practice at CRA. He has 30 years of experience in a variety of senior health care and life science positions as a consultant, payer, and pharmacist. Stephen has led engagements on a broad variety of commercial issues. He has worked across a...

Martina operates at the forefront of functional developments in Market Access, Pricing & HEOR, Epidemiology and Real World Evidence (RWE) to advance state-of-the-art standards and ensure they are consistently applied and met throughout the organization from drug development, via product...

Wim Goettsch, PhD is the current Director of the EUnetHTA JA3 (2016-2020) Directorate. Between 2010 and 2015 he was the Project Leader of WP5 of the EUnetHTA JA1 and JA2 on Relative Effectiveness Assessments. Until the beginning of 2013, he was also the Deputy Secretary of the Medicinal Products...

Adam has worked for Pfizer for 12 years. His current role is Senior Director in Pfizer’s Global Health and Value Innovation Center, working on new approaches to market access.  Previously, Adam has worked in Pfizer’s international policy division and led Pfizer’s work on science policy in Europe...

Patrick is Executive Director World Wide Health Economics and Outcomes Research (WWHEOR) Markets at Bristol Myers Squibb. He leads the team responsible for supporting country HTA submissions and access. He is responsible for all countries outside of the US. Patrick also leads WWHEOR HTA Policy...

Scientific Director, RMEDS Quantitative Sciences, Janssen Pharm R&D. A former UK NHS healthcare & voluntary sector professional working in the pharmaceutical and diagnostics industry with a 360° experience in the blood borne virus market based on a professional heritage in the viral...

Wills Hughes-Wilson is Head of Patient Access & Commercial Planning at Mereo Biopharma and a member of the company’s executive leadership team.  She joined Mereo in February 2018 with responsibility for leading and optimising the company’s patient access and commercialisation strategies. Prior...

Basmah Khogeer is an Engagement Manager in the Global Pricing, Market Access and Analytics line at Precision Xtract. Basmah brings 3 years consulting experience focusing on pricing and market access in a variety of therapeutic areas including oncology, haematology, rheumatoid arthritis and rare/...

Diane Kleinermans works as advisor to the Minister of Public Health and Social Affairs since 2015. She is mainly in charge of dossiers related to clinical trials but also of the BeNeLuxA cooperation’s initiative. Diane has a medical background and a broad experience in various fields. She started...

Alison Kneen is a Practice Lead at DRG Abacus. She has a passion for market access and public affairs and is seen as a global expert in all aspects of market access and reimbursement strategies. She brings extensive international experience built over 34 years in the pharmaceutical industry, with...

Akshay Kumar – Senior Director -Dr. Akshay Kumar is a Senior Director with 11+ years of experience helping pharmaceutical and biotech companies develop market access & pricing solutions - which are aligned to their broader commercial, organizational and environmental context. These solutions...

Adam is a Senior Global Payer Strategy Manager working in oncology pipeline at Boehringer Ingelheim. He is managing global pricing and market access strategies for the oncology portfolio and driving the development of innovative market access approaches and payment schemes. Since September 2015 he...

Oliver has worked for 18 years in market access for both big and small pharma, as well as in European and Global Market Access Consultancy.  Oliver is currently Vice President and Global Head of Value & Access for Certara.  Oliver’s expertise is in Fast-Track medicine approvals and...

Giovanny current role is Pricing & Access Regional Director for Novartis Latin-America & Canada. Nevertheless his interest and area of expertise involves access initiatives for Emerging Markets, developing tools and methodologies  to measure affordability and solutions to overcome the out...

Qing Liu, Ph.D. is currently leading strategic and technical innovations in biostatistics, regulatory and clinical development at Amicus Therapeutics, Inc.Qing is an expert in statistics who gained rich experience in broad disease areas including oncology, neurology (e.g. Alzheimer's...

Francois Lucas - Senior Director -François has more than 20 of years of experience in consulting for the global healthcare industry, with expert knowledge of payer systems and pricing & market access strategy.François has worked across a broad array of therapy areas and geographies around the...

Jörg Mahlich graduated in economics from the University of Kiel/Germany and holds a doctoral degree in economics from the University of Vienna/Austria. He is currently heading the health economics department at Janssen Japan in Tokyo. Previous to that he was in the market access team of Janssen...

Eva Marchese specializes in competitive strategy, pricing, market access, and research primarily in the pharmaceutical, biotech, and life sciences industries. She has an extensive consulting background with a focus on advising pharmaceutical and medical device companies on global pricing and market ...

Dr. Kevin Walker Mayo is  Global Head, Market Access New Products for PTC Therapeutics where he is supporting their gene therapy, alternative splicing, nucleotide repeat, protein modification, transcript regulators and nonsense readthrough scientific platforms for discovering rare disease...

Patrick Mollon, MD, ESSEC MBA, MSc acquired his medical qualification in Lyon’sSchool of Medicine, France where he also gained a Masters Degree in Medical andBiological Sciences, including Pharmacology, Psychology and Medical Statistics. Priorto this, he received an MBA from the Superior School of...

Elsa Navarro is a Senior Advisor, Market Access Consulting at Evidera. Ms. Navarro has had a lengthy career in the biopharmaceutical industry and has focused on the global market access discipline for over a decade. Ms. Navarro has previously worked at AbbVie as well as Amgen and has led the...

In 1987 he graduated from Pirogov Russian National Research Medical University with a specialization in “General Medicine”. In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration with a specialization in “State and Municipal Management”. In 1991 he...

Rafaat founded Lifescience Dynamics in the summer of 2004. Now 14 years on, Lifescience Dynamics is privileged to boast an extraordinary worldwide customer base with teams across the globe supporting firms of all sizes, from top 20 pharmaceutical companies through to smaller niche pharma and...

Marco Rauland has more than 20 years of drug development, marketing, market research and pricing consulting experience in the pharmaceutical industry. Prior to joining Merck Marco was Vice President Europe of GfK's Market Access practice. Before that Marco was the global head of the...

Ajan Reginald is a co-founder and the Chief Executive Officer of Celixir, which he originally founded under the name Cell Therapy Ltd in 2009 with Nobel Laureate Professor Sir Martin Evans.  Celixir is a British biotechnology company that discovers and develops life-saving and life-altering...

Ayman Semaan leads the Market Access Department at Algorithm/Biologix, covering 18 markets of the Middle East and North Africa (MENA); and holds a principal role in the group’s pricing committee. His experience includes functional and leadership positions (Sales, Marketing, and Access) in various...

Tamir is the Head of Commercial Development in Specialised Commissioning, NHS England and responsible for the negotiations and transactions with Pharmaceutical companies on new high-cost and tariff-excluded drugs for NHS England, such as Managed Access Agreements, promoting innovation and...

Dr. Josep Torrent-Farnell. PhD in Medicine and Surgery and Bachelor of Pharmacy, specialist in internal medicine and clinical pharmacology. Head of the medicine division of the CatSalut, of the Generalitat de Catalunya (May 2016). Full Professor of the Department of Clinical and Therapeutic...

Health Technology Assessment (HTA) specialist with profound experience in technology assessment, development of evidence-based practice guidelines and teaching materials, clinical research, consulting related to health technologies, and academic teaching.

Christina Vandorou is currently the Director of Macroeconomics and Health Policy for Europe, Middle East and Africa at Janssen.In the past she has worked in a variety of Local, European and Global positions in the areas of Health Economics, Pricing and Reimbursement, and Government Affairs and...

Meike has deep experience in designing customer centric strategies, especially also in rare diseases. Her focus is on developing and implementing value-based and beyond-the-pill approaches for diverse customer and stakeholder groups including policy makers, payers, professionals, and patients.